Starting with the lowest effective doses of both compounds and gradually titrating upward allows for better symptom monitoring and safety assessment
Documentation red flags include Certificates of Analysis from unknown or unverifiable testing laboratories, HPLC purity results without corresponding endotoxin or sterility testing, and testing performed by the seller rather than an independent third-party laboratory
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Subjects with diabetes were excluded
Current insight into the cardiovascular biology of GIP is limited, and findings in preclinical and clinical studies point in different directions, ranging from potentially cardioprotective effects to heightened vascular inflammation and artherogenesis 24,25
Saline is cheap enough